EcoDrugPlus

Coagulation Factor Xi

Ensembl ID : ENSPCTG00005007588
Gene Symbol: F11
2 Cross references
216 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSPCTG00005020605
Gene Symbol: CCDC6
1 Cross references
219 Possible Orthologues:

Complement C1s

Ensembl ID : ENSPCTG00005015425
Gene Symbol: C1S
1 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSPCTG00005017275
Gene Symbol: C5
3 Cross references
208 Possible Orthologues:

Complement Factor D

Ensembl ID : ENSPCTG00005009692
Gene Symbol: CFD
1 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSPCTG00005016827
Gene Symbol: CRHR1
3 Cross references
240 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSPCTG00005012393
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSPCTG00005008697
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cytochrome P450 11b1, Mitochondrial

Ensembl ID : ENSPCTG00005014680
Gene Symbol: LOC102988484
3 Cross references
45 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSPCTG00005020262
Gene Symbol: CYP17A1
1 Cross references
210 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSPCTG00005021886
Gene Symbol: CYP26A1
2 Cross references
207 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSPCTG00005021391
Gene Symbol: CYP46A1
2 Cross references
259 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).